CoChat

Rapid Reversal of Acute Psychosis in the Cushing Syndrome with the Cortisol-Receptor Antagonist Mifepristone (RU 486)

van der Lely, Aart-Jan, Foeken, Karin, van der Mast, Roos C., Lamberts, Steven W. J. · 1991 · Annals of Internal Medicine
Cited by 105

The DOI matches its Crossref record.

Abstract

Brief Reports15 January 1991Rapid Reversal of Acute Psychosis in the Cushing Syndrome with the Cortisol-Receptor Antagonist Mifepristone (RU 486)Aart-Jan van der Lely, MD, Karin Foeken, MD, Roos C. van der Mast, MD, Steven W. J. Lamberts, MDAart-Jan van der Lely, MD, Karin Foeken, MD, Roos C. van der Mast, MD, Steven W. J. Lamberts, MDAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-114-2-143 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe progesterone-receptor antagonist, RU 486 (mifepristone), is also, at higher concentrations, an effective antagonist of glucocorticoid action in vitro and in vivo (1-3). In normal humans, RU 486 blocks glucocorticoid negative feedback at the hypothalamic-pituitary level, inducing a compensatory increase in plasma adrenocorticotropin (ACTH) and cortisol levels (4, 5). In previous studies, patients with the Cushing syndrome caused by ectopic ACTH secretion or by adrenocortical carcinomas who received therapy with RU 486 (5 to 22 mg/kg body weight per day) showed clinical improvement, and no compensatory increases in plasma ACTH or cortisol levels were noted, probably because of ongoing hypothalamic...References1. Philibert D, Deraedt R, and Teutsch G. RU 486: a potent antiglucocorticoid in vivo [Abstract]. International Congress of Pharmacology, Tokyo, Japan; 1981:1463. Google Scholar2. Proux-Ferland L, Cote J, Philibert D, and Deraedt R. Potent antiglucocorticoid activity of RU 38486 on ACTH secretion in vitro and in vivo in the rat [Abstract]. J Steroid Biochem. 1982;17:xvii. Google Scholar3. Lamberts S, Bons E, and Uitterlinden P. Studies on the glucocorticoid receptor blocking action of RU 38486 in cultured ACTH-secreting human pituitary tumor cells and normal rat pituitary cells. Acta Endocrinol (Copenh). 1985;109:64-9. CrossrefMedlineGoogle Scholar4. Bertagna X, Bertagna C, Luton J, Husson J, and Girard F. The new steroid analogue RU 486 inhibits glucocorticoid action in man. J Clin Endocrinol Metab. 1984;59:25-31. CrossrefMedlineGoogle Scholar5. Gaillard R, Poffet D, Diondel A, and Saurat J. RU 486 inhibits peripheral effects of glucocorticoids in humans. J Clin Endocrinol Metab. 1985;61:1009-14. CrossrefMedlineGoogle Scholar6. Bertagna X, Bertagna C, Laudat M, Husson J, Girard F, and Luton Z. Pituitary-adrenal response to the antiglucocorticoid action of RU 486 in Cushing's syndrome. J Clin Endocrinol Metab. 1986;63:639-42. CrossrefMedlineGoogle Scholar7. Nieman L, Chrousos G, and Nisula B. Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. J Clin Endocrinol Metab. 1985;61:536-40. CrossrefMedlineGoogle Scholar8. Nieman L, Udelsman R, Loriaux D, and Chrousos C. Antiglucocorticoids: basic and clinical studies. In: D'Agata R, Chrousos GP, eds. Recent Advances in Adrenal Regulation and Function. New York: Raven Press; 1987:235-58. Google Scholar9. Haskett R. Diagnostic categorization of psychiatric disturbance in Cushing's syndrome. Am J Psychiatry. 1985;142:911-6. CrossrefMedlineGoogle Scholar10. Laue L, Callucci W, Loriaux D, Udelsman R, and Chrousos G. The antiglucocorticoid and antiprogestin steroid RU 486: its glucocorticoid agonist effect is inadequate to prevent adrenal insufficiency in primates. J Clin Endocrinol Metab. 1988;67:602-6. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: Aart-Jan van der Lely, MD; Karin Foeken, MD; Roos C. van der Mast, MD; Steven W. J. Lamberts, MDFrom Erasmus University, Rotterdam, The Netherlands. For current author addresses, see end of text. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byGlucocorticoids and cognitive function: a walkthrough in endogenous and exogenous alterationsMifepristone's effects on depression- and anxiety-like behavior in rodentsEndokrine StörungenSex differences in the hypothalamic–pituitary–adrenal axis: An obstacle to antidepressant drug development?Glucocorticoid and Mineralocorticoid Receptors in the Brain: A Transcriptional PerspectiveManage psychiatric symptoms in Cushing's syndrome by controlling cortisol levels and usual psychiatric therapyMifepristone Plasma Level and Glucocorticoid Receptor Antagonism Associated With Response in Patients With Psychotic DepressionPsychiatric Symptoms in Patients with Cushing's Syndrome: Prevalence, Diagnosis and ManagementUpdate on medical treatment for Cushing's diseaseA Mixed Glucocorticoid/Mineralocorticoid Selective Modulator With Dominant Antagonism in the Male Rat BrainAnna-Monika Award Lecture, DGPPN Kongress, 2013: The role of the hypothalamic–pituitary–adrenal (HPA) axis in the pathogenesis of psychotic major depressionTreatment of Cushing's disease: a mechanistic updateNext Generation Medical Therapy for Cushing's Syndrome—Can We Measure a Benefit?Hypothalamic

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-114-2-143

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 105

Metadata

Authors
van der Lely, A.-J., Foeken, K., van der Mast, R. C., & Lamberts, S. W. J.
Venue
Annals of Internal Medicine
Published
1991-01-15
Volume
114
Issue
2
Pages
143-144
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W1987840185
Cited by
105
References
0
FWCI
1.98
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rapid Reversal of Acute Psychosis in the Cushing Syndrome with the Cortisol-Receptor Antagonist Mifepristone (RU 486). https://app.cochat.ai/papers/10.7326/0003-4819-114-2-143
The paper
van der Lely, A.-J., Foeken, K., van der Mast, R. C., & Lamberts, S. W. J. (1991). Rapid Reversal of Acute Psychosis in the Cushing Syndrome with the Cortisol-Receptor Antagonist Mifepristone (RU 486). Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-114-2-143

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.